It was reported in a literature article (feldman, a.T., goff, b.J.Epidural analgesia to facilitate scs trial after previous trial failed due to intolerable pain (10678).North american neuromodulation society 19th annual meeting.2015.347.) that the patient still reported focal thoracic spine discomfort without dermatomal bands wrapping anteriorly or distal neurological signs/symptoms.This pain persisted throughout their otherwise successful week-long trial.Discomfort was relieved with lead removal, and thoracic spine mri demonstrated no anomaly.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|